HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas Gruenberger Selected Research

Messenger RNA (mRNA)

11/2016Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas Gruenberger Research Topics

Disease

28Neoplasm Metastasis (Metastasis)
01/2020 - 03/2002
20Neoplasms (Cancer)
11/2018 - 03/2002
16Colorectal Neoplasms (Colorectal Cancer)
08/2020 - 03/2002
8Liver Diseases (Liver Disease)
01/2021 - 07/2014
5Hepatocellular Carcinoma (Hepatoma)
07/2017 - 10/2007
4Fibrosis (Cirrhosis)
12/2022 - 02/2010
2Hemorrhage
12/2022 - 04/2008
2Inflammation (Inflammations)
01/2022 - 11/2005
2Biliary Tract Neoplasms (Biliary Tract Cancer)
12/2010 - 06/2009
1Leukopenia
12/2022
1Hypersplenism (Anemia, Splenic)
12/2022
1Thrombocytopenia (Thrombopenia)
12/2022
1Cytopenia
12/2022
1Anemia
12/2022
1Febrile Neutropenia
08/2020
1Diarrhea
08/2020
1Neutropenia
08/2020
1Adenoma (Adenomas)
07/2017
1Liver Failure
12/2013
1Lymphatic Metastasis
02/2012
1Wounds and Injuries (Trauma)
06/2011
1Acquired Immunodeficiency Syndrome (AIDS)
06/2011
1Non-alcoholic Fatty Liver Disease
02/2011
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
02/2011
1Carcinogenesis
01/2009
1Adenocarcinoma
08/2007
1Cholecystitis
11/2005
1Carcinoma (Carcinomatosis)
11/2005
1Sclerosis
06/2003

Drug/Important Bio-Agent (IBA)

10Bevacizumab (Avastin)FDA Link
08/2020 - 04/2008
7Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2013 - 04/2008
6Biomarkers (Surrogate Marker)IBA
11/2018 - 07/2014
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2016 - 04/2008
3Irinotecan (Camptosar)FDA LinkGeneric
01/2013 - 10/2008
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2016 - 06/2011
2Fluorouracil (Carac)FDA LinkGeneric
11/2013 - 01/2010
2Leucovorin (Folinic Acid)FDA Link
11/2013 - 01/2010
2Pharmaceutical PreparationsIBA
01/2013 - 02/2010
2Carcinoembryonic AntigenIBA
09/2012 - 03/2002
2Cetuximab (Erbitux)FDA Link
12/2010 - 01/2010
2XELOXIBA
08/2010 - 04/2008
2TOR Serine-Threonine KinasesIBA
06/2009 - 08/2007
2Monoclonal AntibodiesIBA
10/2008 - 04/2008
1Interleukin-6 (Interleukin 6)IBA
01/2022
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2021
1Serotonin and Noradrenaline Reuptake InhibitorsIBA
01/2021
1von Willebrand FactorIBA
11/2018
1Tumor Biomarkers (Tumor Markers)IBA
11/2018
1Genetic Markers (Genetic Marker)IBA
11/2018
1DNA (Deoxyribonucleic Acid)IBA
11/2018
1AntigensIBA
01/2018
1Serotonin (5 Hydroxytryptamine)IBA
12/2017
1clonidine-displacing substance (ClDS)IBA
07/2017
1Antithrombin IIIIBA
01/2017
1Messenger RNA (mRNA)IBA
11/2016
1Proteins (Proteins, Gene)FDA Link
08/2016
1Thrombospondin 1IBA
05/2016
1P-SelectinIBA
05/2016
1AngiopoietinsIBA
06/2015
1Thrombopoietin (c-mpl Ligand)IBA
01/2015
1gadolinium ethoxybenzyl DTPAFDA Link
12/2013
1BilirubinIBA
12/2013
1Indicators and Reagents (Reagents)IBA
01/2012
1CytokinesIBA
01/2012
1gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
02/2011
1Alkaline PhosphataseIBA
02/2011
1GemcitabineFDA Link
12/2010
1Biological ProductsIBA
08/2010
1Doxorubicin (Adriamycin)FDA LinkGeneric
02/2010
1Sirolimus (Rapamycin)FDA Link
06/2009
1Mitogen-Activated Protein KinasesIBA
06/2009
1ErbB Receptors (EGF Receptor)IBA
06/2009
1Nitrous Oxide (Laughing Gas)IBA
02/2009
1Remifentanil (Ultiva)FDA Link
02/2009
1IsofluraneFDA LinkGeneric
02/2009
1NitrogenIBA
02/2009
1Epidermal Growth Factor (EGF)IBA
01/2009
1Capecitabine (Xeloda)FDA Link
04/2008
1Ethanol (Ethyl Alcohol)IBA
10/2007
1MTOR InhibitorsIBA
08/2007
1beta CateninIBA
11/2005
1Cadherins (E-Cadherin)IBA
11/2005
1Biological FactorsIBA
03/2002

Therapy/Procedure

19Drug Therapy (Chemotherapy)
01/2020 - 03/2002
14Neoadjuvant Therapy
11/2018 - 04/2008
9Therapeutics
08/2020 - 06/2003
3Contraindications
12/2022 - 02/2012
3Adjuvant Chemotherapy
08/2016 - 02/2005
1Surgical Portasystemic Shunt (Portosystemic Shunt)
12/2022
1Transjugular Intrahepatic Portasystemic Shunt
12/2022
1Hepatectomy
01/2015
1Palliative Care (Palliative Therapy)
10/2008
1Combination Drug Therapy (Combination Chemotherapy)
10/2008
1Blood Transfusion (Blood Transfusions)
04/2008
1Lasers (Laser)
10/2007
1Ablation Techniques
10/2007
1Radiofrequency Ablation
10/2007
1Induced Hyperthermia (Thermotherapy)
10/2007
1Laparotomy
06/2003